JPMorgan, Goldman Sachs, Jefferies and RBC Capital are acting as joint book running managers for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IDYA:
- Ideaya Biosciences price target raised to $36 from $32 at RBC Capital
- Ideaya Biosciences price target raised to $35 from $32 at JPMorgan
- Ideaya Biosciences announces expansion of darovasertib, crizotinib combination
- Stifel disagrees with negative reaction in Ideaya shares after Amgen data
- Ideaya has positive read from Amgen PRMT5 data, says Oppenheimer